SUBSCRIBE
SUBSCRIBE
News   Policy

FDA Denies Somaxon Pharmaceuticals, Inc. Approval for Insomnia Drug

February 27, 2009 | 
1 min read
Feb 26 (Reuters) - Somaxon Pharmaceuticals Inc said the U.S. health regulators denied approval for its experimental treatment for insomnia in the present form and raised several issues regarding the efficacy data of the drug.
Regulatory
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Pictured: Novavax/Getty Images, STR/NurPhoto
Vaccines
After Missed Decision Deadline, Novavax Says COVID-19 Shot ‘Approvable’
April 24, 2025
 · 
2 min read
 · 
Tristan Manalac
Contemporary art collage. Human hand holding megaphones and spreading fake news. Concept of information, creativity, social issues, rumors. Copy space for ad
Regulatory
Vanda Escalates Vendetta Against FDA, Blasts ‘Bureaucrats’ for Delaying Stomach Drug
April 24, 2025
 · 
2 min read
 · 
Tristan Manalac
Illustration showing confused man standing on crossroads and looking at signpost with three different directions
Layoffs
Guessing Game: Former HHS Workers’ Next Stops Unclear
April 24, 2025
 · 
5 min read
 · 
Angela Gabriel
Background of scattered on a plain blue background of many tablets in the form of a silhouette of the continents of the world 3d illustration
Drug pricing
Trump Wants To Bring Back International Drug Pricing Policy: Reuters
April 23, 2025
 · 
2 min read
 · 
Annalee Armstrong